Scott B Campbell
Overview
Explore the profile of Scott B Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mohammadi M, Okhovatian S, Savoji H, Campbell S, Lai B, Wu J, et al.
Adv Biol (Weinh)
. 2022 Jul;
6(11):e2101165.
PMID: 35798316
Despite current efforts in organ-on-chip engineering to construct miniature cardiac models, they often lack some physiological aspects of the heart, including fiber orientation. This motivates the development of bioartificial left...
12.
Ethier I, Campbell S, Cho Y, Hawley C, Isbel N, Krishnasamy R, et al.
Nephrology (Carlton)
. 2022 Jun;
27(8):663-672.
PMID: 35678544
Aim: The benefits of dialysis in the older population remain highly debated, particularly for certain dialysis modalities. This study aimed to explore the dialysis modality utilization patterns between in-centre haemodialysis...
13.
Chan S, Howell M, Johnson D, Hawley C, Tong A, Craig J, et al.
Clin Transplant
. 2022 Apr;
36(6):e14660.
PMID: 35362617
Background: Infections are a common complication following kidney transplantation, but are reported inconsistently in clinical trials. This study aimed to identify the infection outcomes of highest priority for patients/caregivers and...
14.
Chan S, Hawley C, Pascoe E, Cao C, Campbell S, Campbell K, et al.
J Ren Nutr
. 2022 Mar;
32(6):718-725.
PMID: 35248721
Objectives: Modulating the large intestinal microbiome of kidney transplant recipients (KTRs) may reduce infectious complications. The aim of this study is to assess the feasibility of a randomized controlled trial...
15.
Lu R, Lai B, Rafatian N, Gustafson D, Campbell S, Banerjee A, et al.
Lab Chip
. 2022 Feb;
22(6):1171-1186.
PMID: 35142777
Coronavirus disease 2019 (COVID-19) was primarily identified as a novel disease causing acute respiratory syndrome. However, as the pandemic progressed various cases of secondary organ infection and damage by severe...
16.
Yaxley J, Campbell S, Gray N, Viecelli A
Intern Med J
. 2021 Sep;
52(2):206-213.
PMID: 34528751
Background: There has been considerable growth in nephrology advanced trainee numbers in Australia and New Zealand, with uncertain effects on clinical experience, competence and employment outcomes. Aims: To review the...
17.
Pysar R, Wallingford C, Boyle J, Campbell S, Eckstein L, McWhirter R, et al.
Eur J Hum Genet
. 2021 Aug;
29(12):1811-1818.
PMID: 34446835
Human research ethics committees (HRECs) are evaluating increasing quantities of genomic research applications with complex ethical considerations. Genomic confidence is reportedly low amongst many non-genetics-experts; however, no studies have evaluated...
18.
Campbell S, Wu Q, Yazbeck J, Liu C, Okhovatian S, Radisic M
ACS Biomater Sci Eng
. 2021 Jul;
7(7):2880-2899.
PMID: 34275293
Polydimethylsiloxane (PDMS) is the predominant material used for organ-on-a-chip devices and microphysiological systems (MPSs) due to its ease-of-use, elasticity, optical transparency, and inexpensive microfabrication. However, the absorption of small hydrophobic...
19.
Cossart A, Isbel N, Scuderi C, Campbell S, Staatz C
Front Pharmacol
. 2021 Apr;
12:635165.
PMID: 33912051
This review summarizes how possible age-related changes in tacrolimus and cyclosporine pharmacokinetics and pharmacodynamics may influence drug dosing and monitoring in the elderly, and highlights how micro-sampling may be useful...
20.
Kalla S, Ellis R, Campbell S, Doucet B, Isbel N, Tie B, et al.
J Kidney Cancer VHL
. 2021 Apr;
8(1):25-31.
PMID: 33850692
Thrombotic microangiopathy (TMA) is characterised by abnormalities in the walls of arterioles and capillaries, precipitated by hereditary or acquired characteristics, and culminating in microvascular thrombosis because of dysregulated complement activity....